Cerebral	cerebral	O	B_disease
haemorrhage	haemorrhage	O	I_disease
induced	induced	O	O
by	by	O	O
warfarin	warfarin	S_chemical	O
-	-	O	O
the	the	O	O
influence	influence	O	O
of	of	O	O
drug-drug	drug-drug	O	O
interactions	interactions	O	O
.	.	O	O

PURPOSE	purpose	O	O
:	:	O	O
To	to	O	O
evaluate	evaluate	O	O
the	the	O	O
frequency	frequency	O	O
,	,	O	O
severity	severity	O	O
and	and	O	O
preventability	preventability	O	O
of	of	O	O
warfarin-induced	warfarin-induced	O	O
cerebral	cerebral	O	O
haemorrhages	haemorrhages	O	O
due	due	O	O
to	to	O	O
warfarin	warfarin	S_chemical	O
and	and	O	O
warfarin-drug	warfarin-drug	O	O
interactions	interactions	O	O
in	in	O	O
patients	patients	O	O
living	living	O	O
in	in	O	O
the	the	O	O
county	county	O	O
of	of	O	O
Osterg	osterg	O	O
 	 	O	O
tland	tland	O	O
,	,	O	O
Sweden	sweden	O	O
.	.	O	O
METHODS	methods	O	O
:	:	O	O
All	all	O	O
patients	patients	O	O
with	with	O	O
a	a	O	O
diagnosed	diagnosed	O	O
cerebral	cerebral	O	B_disease
haemorrhage	haemorrhage	O	I_disease
at	at	O	O
three	three	O	O
hospitals	hospitals	O	O
during	during	O	O
the	the	O	O
period	period	O	O
2000	2000	O	O
-	-	O	O
2002	2002	O	O
were	were	O	O
identified	identified	O	O
.	.	O	O

Medical	medical	O	O
records	records	O	O
were	were	O	O
studied	studied	O	O
retrospectively	retrospectively	O	O
to	to	O	O
evaluate	evaluate	O	O
whether	whether	O	O
warfarin	warfarin	S_chemical	O
and	and	O	O
warfarin-drug	warfarin-drug	O	O
interactions	interactions	O	O
could	could	O	O
have	have	O	O
caused	caused	O	O
the	the	O	O
cerebral	cerebral	O	B_disease
haemorrhage	haemorrhage	O	I_disease
.	.	O	O

The	the	O	O
proportion	proportion	O	O
of	of	O	O
possibly	possibly	O	O
avoidable	avoidable	O	O
cases	cases	O	O
due	due	O	O
to	to	O	O
drug	drug	O	O
interactions	interactions	O	O
was	was	O	O
estimated	estimated	O	O
.	.	O	O

RESULTS	results	O	O
:	:	O	O
Among	among	O	O
593	593	O	O
patients	patients	O	O
with	with	O	O
cerebral	cerebral	O	B_disease
haemorrhage	haemorrhage	O	I_disease
,	,	O	O
59	59	O	O
(	(	O	O
10	10	O	O
%	%	O	O
)	)	O	O
were	were	O	O
assessed	assessed	O	O
as	as	O	O
related	related	O	O
to	to	O	O
warfarin	warfarin	S_chemical	O
treatment	treatment	O	O
.	.	O	O

This	this	O	O
imply	imply	O	O
an	an	O	O
incidence	incidence	O	O
of	of	O	O
1.7/100,000	1.7/100,000	O	O
treatment	treatment	O	O
years	years	O	O
.	.	O	O

Of	of	O	O
the	the	O	O
59	59	O	O
cases	cases	O	O
,	,	O	O
26	26	O	O
(	(	O	O
44	44	O	O
%	%	O	O
)	)	O	O
had	had	O	O
a	a	O	O
fatal	fatal	O	O
outcome	outcome	O	O
,	,	O	O
compared	compared	O	O
to	to	O	O
136	136	O	O
(	(	O	O
25	25	O	O
%	%	O	O
)	)	O	O
among	among	O	O
the	the	O	O
non-warfarin	non-warfarin	O	O
patients	patients	O	O
(	(	O	O
p	p	O	O
<	<	O	O
0.01	0.01	O	O
)	)	O	O
.	.	O	O

A	a	O	O
warfarin-drug	warfarin-drug	O	O
interaction	interaction	O	O
could	could	O	O
have	have	O	O
contributed	contributed	O	O
to	to	O	O
the	the	O	O
haemorrhage	haemorrhage	O	O
in	in	O	O
24	24	O	O
(	(	O	O
41	41	O	O
%	%	O	O
)	)	O	O
of	of	O	O
the	the	O	O
warfarin	warfarin	S_chemical	O
patients	patients	O	O
and	and	O	O
in	in	O	O
7	7	O	O
of	of	O	O
these	these	O	O
(	(	O	O
12	12	O	O
%	%	O	O
)	)	O	O
the	the	O	O
bleeding	bleeding	O	S_disease
complication	complication	O	O
was	was	O	O
considered	considered	O	O
being	being	O	O
possible	possible	O	O
to	to	O	O
avoid	avoid	O	O
.	.	O	O

CONCLUSIONS	conclusions	O	O
:	:	O	O
Warfarin-induced	warfarin-induced	O	O
cerebral	cerebral	O	O
haemorrhages	haemorrhages	O	O
are	are	O	O
a	a	O	O
major	major	O	O
clinical	clinical	O	O
problem	problem	O	O
with	with	O	O
a	a	O	O
high	high	O	O
fatality	fatality	O	O
rate	rate	O	O
.	.	O	O

Almost	almost	O	O
half	half	O	O
of	of	O	O
the	the	O	O
cases	cases	O	O
was	was	O	O
related	related	O	O
to	to	O	O
a	a	O	O
warfarin-drug	warfarin-drug	O	O
interaction	interaction	O	O
.	.	O	O

A	a	O	O
significant	significant	O	O
proportion	proportion	O	O
of	of	O	O
warfarin-related	warfarin-related	O	O
cerebral	cerebral	O	O
haemorrhages	haemorrhages	O	O
might	might	O	O
have	have	O	O
been	been	O	O
prevented	prevented	O	O
if	if	O	O
greater	greater	O	O
caution	caution	O	O
had	had	O	O
been	been	O	O
taken	taken	O	O
when	when	O	O
prescribing	prescribing	O	O
drugs	drugs	O	O
known	known	O	O
to	to	O	O
interact	interact	O	O
with	with	O	O
warfarin	warfarin	S_chemical	O
.	.	O	O

